FAM72A: A Promising Drug Target and Biomarker for Multiple Chronic Diseases

Target Name: FAM72A

NCBI ID: G729533

FAM72A

FAM72A: A Promising Drug Target and Biomarker for Multiple Chronic Diseases

FAM72A (Protein FAM72A (isoform 1), also known as CDK4 kinase alpha) is a protein that plays a crucial role in the regulation of cell growth, differentiation, and survival. It is a key component of the transforming growth factor-beta (TGF-β) signaling pathway, which is involved in numerous cellular processes, including cell proliferation, differentiation, and survival. The TGF-β pathway is a well-established target for numerous diseases, including cancer, neurodegenerative disorders, and developmental defects. Therefore, the study of FAM72A and its potential as a drug target or biomarker is of great interest.

FAM72A: Structure and Function

FAM72A is a 21-kDa protein that is expressed in various tissues, including liver, pancreas, and muscle. It is a type-I transmembrane protein that consists of an extracellular domain, a transmembrane region, and an intracellular domain. The extracellular domain is involved in the formation of a complex with other proteins, which includes the transcription factor p53. The transmembrane region is responsible for the formation of the protein's monomeric state and is involved in the regulation of cell adhesion and migration. The intracellular domain is involved in the regulation of protein stability and functions, including the regulation of DNA binding and protein-protein interactions.

FAM72A is involved in the regulation of several cellular processes, including cell growth, differentiation, and survival. It plays a role in the TGF-β pathway, which is involved in the regulation of cell growth, differentiation, and survival. FAM72A is a key component of the TGF-β pathway, as it regulates the activity of the transcription factor Smad, which is involved in the regulation of TGF-β signaling pathway.

FAM72A is also involved in the regulation of cell adhesion and migration. It has been shown to play a role in the regulation of cell adhesion, as it has been shown to interact with the adhesion molecule E-cadherin. FAM72A has also been shown to be involved in the regulation of cell migration, as it has been shown to interact with the migration protein,chemokine, and the actinin protein.

FAM72A is also involved in the regulation of protein stability and functions, including the regulation of DNA binding and protein-protein interactions. It has been shown to play a role in the regulation of protein stability by interacting with the protein degradation regulator, p62/p70.

Drug Targeting and Biomarker

FAM72A is a promising drug target for multiple chronic diseases, including cancer, neurodegenerative disorders, and developmental defects. The TGF-β pathway is a well-established target for numerous diseases, including cancer, neurodegenerative disorders, and developmental defects. Therefore, the study of FAM72A and its potential as a drug target or biomarker is of great interest.

FAM72A has been shown to play a role in the regulation of cancer cell growth and survival. Several studies have shown that FAM72A is involved in the regulation of cancer cell growth and survival, including the regulation of cell proliferation and the inhibition of apoptosis. Therefore, FAM72A may be an attractive drug target for cancer treatment.

FAM72A has also been shown to play a role in the regulation of neurodegenerative disorders. The TGF-β pathway is involved in the regulation of neurodegenerative disorders, including Alzheimer's disease and Parkinson's disease. Therefore, FAM72A may be an attractive drug target for neurodegenerative disorders.

FAM72A has also been shown to play

Protein Name: Family With Sequence Similarity 72 Member A

Functions: May play a role in the regulation of cellular reactive oxygen species metabolism. May participate in cell growth regulation

The "FAM72A Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FAM72A comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets